Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Bipolar Disorder market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Bipolar Disordermarket, defines the market attractiveness level of Bipolar Disorder market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Bipolar Disorder industry, describes the types of Bipolar Disorder market, the applications of major players and the market size, and deeply analyzes the current situation of the global Bipolar Disorder market and the development prospects and opportunities of Bipolar Disorder industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Bipolar Disorder market in Chapter 13.
By Player:
Eli Lilly
Novartis
Allergan
Janssen Pharmaceuticals
Glaxo SmithKline (GSK)
AbbVie
Pfizer
Otsuka
AstraZeneca
By Type:
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
By End-User:
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Bipolar Disorder Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Bipolar Disorder Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Bipolar Disorder Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Bipolar Disorder Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Bipolar Disorder Market Analysis and Outlook to 2022
-
7.1 Global Bipolar Disorder Consumption (2017-2022)
-
7.2 United States Bipolar Disorder Consumption (2017-2022)
-
7.3 Europe Bipolar Disorder Consumption (2017-2022)
-
7.4 China Bipolar Disorder Consumption (2017-2022)
-
7.5 Japan Bipolar Disorder Consumption (2017-2022)
-
7.6 India Bipolar Disorder Consumption (2017-2022)
-
7.7 South Korea Bipolar Disorder Consumption (2017-2022)
8 Region and Country-wise Bipolar Disorder Market Analysis and Outlook to 2028
-
8.1 Global Bipolar Disorder Consumption Forecast (2022-2028)
-
8.2 United States Bipolar Disorder Consumption Forecast (2022-2028)
-
8.3 Europe Bipolar Disorder Consumption Forecast (2022-2028)
-
8.4 China Bipolar Disorder Consumption Forecast (2022-2028)
-
8.5 Japan Bipolar Disorder Consumption Forecast (2022-2028)
-
8.6 India Bipolar Disorder Consumption Forecast (2022-2028)
-
8.7 South Korea Bipolar Disorder Consumption Forecast (2022-2028)
9 Global Bipolar Disorder Market Outlook by Types and Applications to 2022
-
9.1 Global Bipolar Disorder Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Selective Serotonin Reuptake Inhibitor Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Serotonin Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Tricyclic Antidepressants Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Benzodiazepines Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
9.2 Global Bipolar Disorder Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Antipsychotic drugs Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Antidepressant drugs Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Antianxiety drugs Consumption and Growth Rate (2017-2022)
10 Global Bipolar Disorder Market Outlook by Types and Applications to 2028
-
10.1 Global Bipolar Disorder Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Selective Serotonin Reuptake Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Serotonin Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Tricyclic Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Benzodiazepines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Bipolar Disorder Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Antipsychotic drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Antidepressant drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Antianxiety drugs Consumption Forecast and Growth Rate (2022-2028)
11 Global Bipolar Disorder Import and Export Analysis (Top 5 Countries)
-
11.1 Global Bipolar Disorder Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Bipolar Disorder Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Bipolar Disorder Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Bipolar Disorder Market Competitive Analysis
-
14.1 Eli Lilly
-
14.1.1 Eli Lilly Company Details
-
14.1.2 Eli Lilly Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly Bipolar Disorder Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Bipolar Disorder Product and Service
-
14.3 Allergan
-
14.3.1 Allergan Company Details
-
14.3.2 Allergan Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Allergan Bipolar Disorder Product and Service
-
14.4 Janssen Pharmaceuticals
-
14.4.1 Janssen Pharmaceuticals Company Details
-
14.4.2 Janssen Pharmaceuticals Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Janssen Pharmaceuticals Bipolar Disorder Product and Service
-
14.5 Glaxo SmithKline (GSK)
-
14.5.1 Glaxo SmithKline (GSK) Company Details
-
14.5.2 Glaxo SmithKline (GSK) Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Glaxo SmithKline (GSK) Bipolar Disorder Product and Service
-
14.6 AbbVie
-
14.6.1 AbbVie Company Details
-
14.6.2 AbbVie Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AbbVie Bipolar Disorder Product and Service
-
14.7 Pfizer
-
14.7.1 Pfizer Company Details
-
14.7.2 Pfizer Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Pfizer Bipolar Disorder Product and Service
-
14.8 Otsuka
-
14.8.1 Otsuka Company Details
-
14.8.2 Otsuka Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Otsuka Bipolar Disorder Product and Service
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Details
-
14.9.2 AstraZeneca Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Bipolar Disorder Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Bipolar Disorder
-
Figure Bipolar Disorder Picture
-
Table Global Bipolar Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Bipolar Disorder Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Bipolar Disorder Consumption by Country (2017-2022)
-
Figure United States Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Table Europe Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure China Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure Japan Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure India Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure South Korea Bipolar Disorder Consumption and Growth Rate (2017-2022)
-
Figure Global Bipolar Disorder Consumption Forecast by Country (2022-2028)
-
Figure United States Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Bipolar Disorder Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Selective Serotonin Reuptake Inhibitor Consumption and Growth Rate (2017-2022)
-
Figure Global Serotonin Norepinephrine Reuptake Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Tricyclic Antidepressants Consumption and Growth Rate (2017-2022)
-
Figure Global Monoamine Oxidase Inhibitors Consumption and Growth Rate (2017-2022)
-
Figure Global Benzodiazepines Consumption and Growth Rate (2017-2022)
-
Figure Global Beta Blockers Consumption and Growth Rate (2017-2022)
-
Figure Global Mood Stabilizers Consumption and Growth Rate (2017-2022)
-
Figure Global Anticonvulsants Consumption and Growth Rate (2017-2022)
-
Figure Global Antipsychotic drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antidepressant drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Antianxiety drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Selective Serotonin Reuptake Inhibitor Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Serotonin Norepinephrine Reuptake Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Tricyclic Antidepressants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoamine Oxidase Inhibitors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Benzodiazepines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Beta Blockers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Mood Stabilizers Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Anticonvulsants Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antipsychotic drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antidepressant drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antianxiety drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Bipolar Disorder Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Bipolar Disorder Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly Bipolar Disorder Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Bipolar Disorder Product and Service
-
Table Allergan (Foundation Year, Company Profile and etc.)
-
Table Allergan Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Allergan Bipolar Disorder Product and Service
-
Table Janssen Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Janssen Pharmaceuticals Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Janssen Pharmaceuticals Bipolar Disorder Product and Service
-
Table Glaxo SmithKline (GSK) (Foundation Year, Company Profile and etc.)
-
Table Glaxo SmithKline (GSK) Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxo SmithKline (GSK) Bipolar Disorder Product and Service
-
Table AbbVie (Foundation Year, Company Profile and etc.)
-
Table AbbVie Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table AbbVie Bipolar Disorder Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Bipolar Disorder Product and Service
-
Table Otsuka (Foundation Year, Company Profile and etc.)
-
Table Otsuka Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table Otsuka Bipolar Disorder Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Bipolar Disorder Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Bipolar Disorder Product and Service
-
